Samuel Granata
22 IP cases indexed. Covers patent matters.
Cases Presided Over
22 cases indexed | Page 1 of 1
BTL Medizintechnik GmbH v.Lexter Microelectronic Engineering Systems S.L.
1 The Hague - Local Division UPC-CFI-1048/2025 Decision of the Court of First Instance of the Unified Patent Court issued on 16/01/2026 regarding: withdrawal Claimant 1) BTL Medizintechnik GmbH Represented by Tobias Wuttke Prinzregentenplatz 7, 81675, Munich, Germany
CooperSurgical, Inc. v.European Distribution Center Motiva BVBA, Establishment Labs S.A. and PulseLavage AB
This case concerned an infringement action filed by CooperSurgical, Inc. before the Unified Patent Court (Local Division Brussels) regarding EP 3 302 292 B1. After the European Patent Office Opposition Division revoked the patent on 30 September 2025, the Claimant withdrew the action. The Court allowed the withdrawal and assessed the costs to be reimbursed to the Defendants, ordering the Claimant to pay €105,757.90 to Defendants 1-2 and €81,423.33 to Defendant 3, while also ordering reimbursement of 60% of the court fees to the Claimant.
BARCO NV v.1. YEALINK (XIAMEN) NETWORK TECHNOLOGY Co. Ltd. and 2. YEALINK (EUROPE) NETWORK TECHNOLOGY BV
Infringement proceedings concerning EP 3 732 827 before the Local Division Brussels. YEALINK filed a Preliminary Objection challenging the territorial competence of the Brussels Local Division under Article 33(1)(a) UPCA. After the Court of Appeal confirmed the Brussels Local Division's territorial competence in a related cross-appeal, YEALINK withdrew its Preliminary Objection, and the Court closed the preliminary objection proceedings.
Barco NV v.Yealink (Xiamen) Network Technology Co. Ltd. - Yealink (Europe) Network Technology BV
This is a procedural order from the Local Division Brussels of the Unified Patent Court in infringement proceedings concerning EP 3 732 827. Yealink filed a Preliminary Objection under R. 19 RoP challenging the territorial competence of the LD Brussels under Article 33(1)(a) UPCA. Because the same territorial competence issue was already the subject of a cross-appeal pending before the UPC Court of Appeal in case UPC_CoA_317/2025, the Court stayed the Preliminary Objection proceedings until the Court of Appeal issues its decision, and set a schedule for post-decision comments.
Occlutech GmbH v.Lepu Medical (Europe) Cooperatief U.A. a.o.
Occlutech GmbH, proprietor of European Patent EP 2 387 951 B1 covering a braided implantable occlusion device, sought provisional measures against Lepu Medical entities for alleged infringement with their 'MemoCarna ASD' and 'MemoCarna VSD' devices. The Local Division Hamburg held that the Defendants' recent CE-mark approval, combined with their public marketing activities and trade fair participation, established imminent infringement and territorial jurisdiction in Germany. The court granted the preliminary injunction, ordering the Defendants to cease and desist from offering, placing on the market, or using the infringing devices in Germany, France, Italy, the Netherlands, and Ireland, with a penalty of up to EUR 250,000 per non-compliance.
Shangrao Xinyuan Yuedong Technology Development Co., Ltd v.LONGi Solar Technologie GmbH a.o.
The Claimant filed a patent infringement action against five Defendants concerning European patent EP 3 297 043 B1. Following settlement negotiations, the Claimant and Defendants 1–4 reached a comprehensive settlement agreement, and Defendant 5 agreed to the withdrawal. The Court permitted the withdrawal, declared the proceedings closed, ordered each party to bear its own extrajudicial costs, and granted the Claimant a 60% reimbursement of court fees (€6,600).
Merz Therapeutics GmbH, Merz Pharma France, Merz Pharmaceuticals LLC v.Respondent
1 Paris Local Division UPC_CFI_697/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 17/09/2025 APPLICANTS 1) Merz Therapeutics GmbH Eckenheimer Landstraße 100 60318 Frankfurt am Main - DE 2) Merz Pharmaceuticals LLC Unit 35/36, 6601 Six Forks Road, 4th Fl
UPC Decision UPC-000366 v.Respondent
This case concerns an application for provisional measures (preliminary injunction) filed by Washtower IP B.V. and Washtower B.V. against several defendants, including members of the BEGA group of companies, alleging infringement of European Patent EP3522755B1. The patent relates to a cabinet designed to house a washing machine or washer-dryer at waist level for ergonomic use. The application against the first defendant, Wasombouw B.V., was withdrawn shortly after filing, while the proceedings continued against the remaining defendants. The Local Division The Hague of the Court of First Instance held an oral hearing on 14 August 2025 and issued its order on 11 September 2025.
Washtower v.INDUSTRIEBETEILIGUNGS- UND BERATUNGS GMBH et al
Washtower IP B.V. and Washtower B.V. (Applicants), proprietors of European Patent EP3522755B1 relating to cabinets for housing washing machines at waist level, sought provisional measures against several defendants from the BEGA furniture group and a related partner company. The application concerned alleged infringement of the patent by the defendants' manufacture and sale of competing washing machine cabinets. The Local Division The Hague issued an order on provisional measures following an oral hearing held on 14 August 2025, after the Applicants filed their application on 28 May 2025 and the parties exchanged submissions including objections, replies, and rejoinders.
Genentech INC., F.Hoffmann – La Roche AG v.Organon & Co., Organon Heist B.V., NV Organon, Shangai Henlius Biotech INC
Genentech Inc. and F. Hoffmann-La Roche AG (the proprietors of EP 3 401 335 B1, relating to pharmaceutical formulations of HER2 antibodies used in Perjeta®) applied to the Local Division Brussels of the Unified Patent Court for an order to preserve evidence and an order for inspection against Organon entities and Shanghai Henlius Biotech Inc., who are preparing to launch HLX11, a biosimilar of Perjeta®. The court granted both applications, appointing independent technical experts to inspect the defendants' premises and preserve evidence of alleged patent infringement, subject to conditions including a security deposit and limitations on the use of the evidence obtained.
Yealink (Europe) Network Technology B.V., Yealink (Xiamen) Network Technology Co. Ltd. v.Respondent
Yealink applied for rectification of a final order issued by the Local Division Brussels on 21 March 2025 in proceedings concerning EP 3 732 827, seeking to amend the operative part to explicitly characterize the cost award as an 'interim award' and add a reference to Rule 211(1)(d) RoP. The Court dismissed the application, holding that the grounds for rectification under R. 353 RoP are limited to clerical errors, miscalculations, and obvious omissions, none of which were present. The Court reasoned that the order must be read as a whole, and the existing reference to R. 150(2) RoP already encompasses the concept of an interim award of costs.
Yealink (Xiamen) Network Technology Co. Ltd., Yealink (Europe) Network Technology B.V. v.Barco N.V.
Barco NV, proprietor of European Patent EP 3 732 827, filed an application for provisional measures against Yealink entities before the Local Division Brussels of the Unified Patent Court. The Court held that the LD Brussels was territorially competent to hear the application, but dismissed the application for provisional measures due to lack of urgency, finding that Barco had acted negligently or hesitated in seeking relief. Barco was ordered to bear the legal costs of the Yealink defendants up to the applicable ceiling of €112,000.
Supponor Oy v.Respondent
This case concerns a patent infringement action brought by AIM Sport Development AG (formerly AIM Sport Vision AG) against five defendants regarding European Patent No. EP3295663. The Helsinki Local Division had initially dismissed the action for lack of competence, but the Court of Appeal set aside that decision and referred the case back. The present procedural order addresses AIM Sport's applications under Rule 263 RoP to amend its claims and grounds, and under Rule 305 RoP to add a new defendant to the proceedings.
Arkyne Technologies S.L. v.Plant-e Knowledge B.V.
The Court of First Instance of the Unified Patent Court (Local Division The Hague) found European Patent EP 2 137 782, owned by Plant-e Knowledge B.V. and relating to a device and method for converting light energy into electrical energy using living plants in microbial fuel cells, to be valid and infringed by equivalence by Arkyne Technologies S.L. (trading as Bioo). The court applied a four-question test for assessing infringement by equivalence and ordered Bioo to cease infringement, recall infringing products, provide information, publish a corrective notice on its website, pay provisional damages of EUR 35,000, and pay penalties for non-compliance.
Plant-e B.V., Plant-e Knowledge B.V. v.Arkyne Technologies S.L.
The Court of First Instance of the Unified Patent Court (Local Division The Hague) ruled that European Patent EP 2 137 782, owned by Plant-e Knowledge B.V. and relating to a device and method for converting light energy into electrical energy using living plants, is valid and infringed by Arkyne Technologies S.L. (trading as Bioo). The court found infringement by equivalence and ordered Bioo to cease infringing activities, provide information, publish a recall notice on its website, pay provisional damages of EUR 35,000, and pay penalties for any further infringement.
*** v.OrthoApnea S.L., Vivisol B BV
This is a procedural order issued by the Court of First Instance, Local Division Brussels, in an infringement action concerning European Patent EP 2 331 036. The order was issued following an Interim Conference held on 6 September 2024 under Rule 105.5 of the Rules of Procedure. The court explored the possibility of an amicable settlement between the parties, noting willingness on the plaintiff's side and limited willingness on the defendants' side, primarily due to substantial costs already incurred.
Amgen Inc. v.Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland GmbH, Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A.
Amgen Inc. brought a patent infringement action against Sanofi and Regeneron entities concerning European Patent 3,666,797 and their drug Praluent (Alirocumab). The defendants had filed revocation actions, and the Central Division revoked the patent in its entirety on 16 July 2024. Both parties agreed to stay the infringement proceedings pending the outcome of the appeal against the revocation decision, and the court granted the stay.
OrthoApnea S.L. v.Respondent
This is a procedural decision of the Local Division Brussels concerning an Application for Review filed by the defendants against a prior case management order. The defendants, OrthoApnea S.L. and VIVISOL B BV, sought review of Order ORD_37783/2024 of 8 July 2024, which had rejected their objection against the claimant's equivalence arguments while granting an extension for filing a Statement of Rejoinder until 1 August 2024. The underlying dispute relates to European Patent EP 2 331 036 and concerns the permissibility of the claimant supplementing factual context, adding equivalence-based infringement arguments, and adjusting the prayer for relief in their Reply to the Statement of Defence.
OrthoApnea S.L. v.Respondent
This case concerns an infringement action before the Local Division Brussels regarding European Patent EP 2 331 036. The Defendants filed a Generic Procedural Application on June 24, 2024, objecting to the Claimant's Reply to the Statement of Defence. The dispute centers on whether the Claimant may supplement the factual framework, add an equivalence-based infringement argument, and adjust the prayer for relief in his Reply. The Judge-Rapporteur issued a definitive procedural order on July 8, 2024, following a provisional order of June 25, 2024 that invited further submissions from both parties.
Union des Associations Européennes de Football (UEFA), Kinexon Sports & Media GmbH, Kinexon GmbH v.Ballinno B.V.
Ballinno B.V., proprietor of European Patent EP 1 944 067 B1 relating to a method and system for detecting offside situations, sought a preliminary injunction against UEFA and Kinexon entities in connection with the 'Connected Ball Technology' used at the UEFA European Football Championship 2024. The court denied the application, finding that the claimant had waited almost three months after learning of the alleged infringement without taking significant steps to investigate or obtain supporting documents, thereby failing to demonstrate the urgency required for a preliminary injunction.
Steindl Krantechnik Gesellschaft m.b.H. v.BEHA Bau- und Forstgreiftechnik, Inh. Georg Beha e.K.
This case concerned an application for provisional measures related to European Patent EP 3 287 315 before the Local Chamber Munich. Following an oral hearing on January 30, 2024, the parties reached a preliminary settlement, and the claimant subsequently filed an application under Rule 365 of the Rules of Procedure to confirm the settlement. The defendant consented to the settlement and both parties jointly requested its confirmation, confidentiality of its details, and noted that costs were already settled within the agreement.
Plant-e B.V., Plant-e Knowledge B.V. v.Arkyne Technologies S.L.
This procedural order concerns an infringement action (UPC_CFI_239/2023) brought by Plant-e Knowledge B.V. and Plant-e B.V. against Arkyne Technologies S.L. (Bioo) regarding European Patent No. EP2137782. The defendant filed a counterclaim for revocation, raising the question under Article 33(3) UPCA of whether to bifurcate or jointly hear the infringement and revocation proceedings. Both parties jointly requested a joint hearing, and the panel decided to proceed with both matters jointly for reasons of procedural expediency and to ensure a uniform interpretation of the patent.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.